HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald E Cutlip Selected Research

high fluorescent intermediate II

1/2022Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
1/2022Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald E Cutlip Research Topics

Disease

72Myocardial Infarction
01/2019 - 03/2002
68Thrombosis (Thrombus)
01/2022 - 09/2002
29Hemorrhage
01/2022 - 01/2009
21Cardiovascular Diseases (Cardiovascular Disease)
11/2018 - 03/2002
16Death (Near-Death Experience)
01/2022 - 10/2007
16Stroke (Strokes)
01/2019 - 10/2004
15Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 08/2005
13Ischemia
01/2018 - 01/2006
11Pathologic Constriction (Stenosis)
12/2015 - 06/2004
10Diabetes Mellitus
05/2016 - 12/2002
8AIDS-Related Complex (ARC)
01/2021 - 03/2007
7Renal Artery Obstruction (Renal Artery Stenosis)
01/2019 - 01/2014
7Chronic Renal Insufficiency
01/2019 - 11/2006
6Acute Coronary Syndrome
01/2022 - 07/2008
6Heart Failure
01/2022 - 01/2014
5ST Elevation Myocardial Infarction
11/2014 - 11/2006
4Hypertension (High Blood Pressure)
01/2022 - 12/2002
4Peripheral Arterial Disease
01/2017 - 01/2012
4Renal Insufficiency (Renal Failure)
11/2016 - 09/2007
3Coronary Disease (Coronary Heart Disease)
10/2016 - 08/2005
3Myocardial Ischemia (Ischemic Heart Diseases)
04/2016 - 08/2005
3Carotid Stenosis (Carotid Artery Stenosis)
07/2010 - 10/2004
3Coronary Restenosis
10/2007 - 06/2004
3Disease Progression
12/2006 - 09/2004
2Ischemic Stroke
04/2021 - 01/2017
2Kidney Diseases (Kidney Disease)
12/2019 - 11/2016
2Heart Diseases (Heart Disease)
10/2017 - 01/2010
2Inflammation (Inflammations)
01/2017 - 05/2013
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2017 - 10/2011
2Albuminuria
11/2016 - 01/2016
2Infarction (Infarctions)
05/2016 - 04/2016
2Neoplasms (Cancer)
01/2016 - 12/2009
2Isolated Systolic Hypertension
01/2016 - 01/2014
2Coronary Stenosis (Coronary Artery Stenosis)
12/2013 - 10/2008
2Aortic Valve Stenosis (Aortic Stenosis)
01/2011 - 01/2011
2Carotid Artery Diseases
04/2008 - 10/2004
1Acquired Immunodeficiency Syndrome (AIDS)
05/2016
1Atherosclerosis
07/2014
1Variant Angina Pectoris (Prinzmetal's Angina)
08/2012
1Heart Arrest (Cardiac Arrest)
08/2012
1Angina Pectoris
05/2012
1Ventricular Fibrillation
09/2011
1Hypothermia
09/2011
1Chest Pain (Chest Pains)
06/2011
1Sudden Death
05/2011

Drug/Important Bio-Agent (IBA)

18thienopyridineIBA
12/2019 - 02/2009
18Paclitaxel (Taxol)FDA LinkGeneric
05/2017 - 03/2007
17Sirolimus (Rapamycin)FDA Link
10/2018 - 04/2004
17MetalsIBA
10/2015 - 04/2004
142'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 12/2010
12omega-Chloroacetophenone (Mace)IBA
01/2022 - 08/2005
10EverolimusFDA Link
10/2018 - 04/2008
10Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2017 - 12/2010
8Pharmaceutical PreparationsIBA
01/2020 - 06/2004
8zotarolimusIBA
12/2013 - 10/2008
5CreatinineIBA
01/2019 - 11/2006
5StreptokinaseFDA Link
01/2017 - 05/2015
5MB Form Creatine KinaseIBA
11/2016 - 05/2003
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 05/2015
4Glycoproteins (Glycoprotein)IBA
04/2008 - 09/2002
3TroponinIBA
04/2012 - 08/2008
3Clopidogrel (Plavix)FDA Link
12/2010 - 04/2008
2high fluorescent intermediate IIIBA
01/2022 - 01/2022
2salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2022
2Cystatin CIBA
01/2019 - 01/2016
2Biomarkers (Surrogate Marker)IBA
11/2018 - 06/2011
2PolymersIBA
10/2018 - 10/2017
2Antihypertensive Agents (Antihypertensives)IBA
01/2016 - 01/2014
2Explosive Agents (Explosives)IBA
01/2011 - 01/2011
2Dihydrotachysterol (AT 10)IBA
12/2009 - 10/2007
2Ticlopidine (Ticlid)FDA LinkGeneric
02/2009 - 04/2008
2Phenobarbital (Luminal)FDA Link
04/2008 - 10/2004
1TicagrelorIBA
01/2022
1poly(bis(trifluoroethoxy)phosphazene)IBA
01/2017
1SmokeIBA
01/2017
1AlbuminsIBA
11/2016
1CholesterolIBA
01/2016
1HDL CholesterolIBA
01/2016
1NitratesIBA
05/2015
1ReninIBA
07/2014
1AngiotensinsIBA
07/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2014
1Angiotensin Receptor AntagonistsIBA
07/2014
1FibrinIBA
05/2013
1Aluminum Oxide (Sapphire)IBA
02/2011

Therapy/Procedure

96Stents
01/2022 - 09/2002
34Therapeutics
01/2022 - 10/2007
27Percutaneous Coronary Intervention
04/2021 - 05/2003
23Drug-Eluting Stents
01/2020 - 06/2004
7Endarterectomy (Thromboendarterectomy)
11/2018 - 10/2004
5Carotid Endarterectomy
04/2016 - 10/2004
3Duration of Therapy
05/2016 - 03/2015
3Transcatheter Aortic Valve Replacement
01/2011 - 05/2009
3Embolic Protection Devices
04/2008 - 03/2002
2Renal Replacement Therapy (Therapies, Renal Replacement)
11/2016 - 01/2014
2Thrombolytic Therapy
11/2014 - 11/2006
2Secondary Prevention
12/2012 - 07/2008
1Chest Tubes (Chest Tube)
01/2022
1Induced Hypothermia
08/2012
1Patient Readmission
09/2011